Ascellus Health, Inc.
About
Issuer
- Entity type
- Corporation
- Jurisdiction
- Delaware
- Sector
- Healthtech
- Headquarters
- Miami, FL
- Street
- 390 Ne 191st Street, Suite 8749
- Zip
- 33179
Offering
- Total offering
- $2.8M
- Amount sold
- $2.1M
- First sale
- Apr 24, 2025
- Min investment
- $0
- Securities
- Equity
- Federal exemption
- Rule 506(b)
- Investors so far
- 9
How this filing compares
Ranked #8 of 23 Healthtech filings in March 2026 by offering amount.
Median Healthtech filing in March 2026: $1M. This offering is 2.8× the median.
Other Florida filings this week: BOLDCHARTER INC, Fiesta Bonita SPV LLC, House of Stone Capital Fund One LLC, Ibis Capital Fund, LP, IMAGINOSTICS, INC.
Leadership
Joseph Holtschlag — Executive Officer (also: Director)
Steven Chrust — Director
Also named on: Cytogel Pharma, LLC
Liam Donohue — Director
Martha Temple — Director
Kevin Wang — Director
Also named on: RELAI, Inc.
Jeff Williams — Executive Officer
Filing details
Ascellus Health, Inc. filed a Form D with the SEC on March 31, 2026.